Delivery Order SPE2DB24D2012-SPE2DB25FBWLS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,255.10 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors on July 30, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with a ceiling value of $1,559.46. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes, and this order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,162.70 for Mounjaro 7.5 mg/0.5 ml pen auto-injectors on July 23, 2025, with completion targeted for July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing part of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units) with a contract ceiling value of $4,786.36. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set for ultimate completion on July 22, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $45,830.70 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,162.70 for Mounjaro 5 mg/0.5 mL pen injectors on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery...
- The Defense Logistics Agency awarded a $5,441.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors (0.5 ml). The contract, which represents a non-set-aside competitive award, is scheduled for completion by July 22, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,088.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors. This is a non-set-aside competitive award with an ultimate completion date of August 12, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes, and this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.85 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control and weight management, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $1,994.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitive award, with no set-aside designation, is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWLSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control and weight management within military and federal healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company's status as a major pharmaceutical distributor and established federal vendor demonstrates its capability to fulfill critical medical supply requirements for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/18/25 |